Picard Medical is trading 11.29% down at $7.50 amid broader risk-off pressure.

  • S&P 500 is down 0.61% and Nasdaq Composite 1.03% as investors digest economic releases and higher-for-longer interest-rate concerns.
  • No new company-specific announcement or clear catalyst was identified for September 1, 2026.
  • The decline follows substantial post-earnings volatility after August 19 results; healthcare-sector strength suggests it is not primarily industry-wide.